$0 consult fee
Many Indian patients who hoped for a one-and-done fix discover that support, follow-up, cost, and lifestyle changes still matter
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
1 (1) zpaa002
Usually patients are their own advocate, so I was thrilled to not have to fight for my coverage." I did my research, but nothing came close to what Ro offered. It feels amazing to have a supportive team that actually listens to me. Im not fighting against my own body anymore
This ongoing competition has shaped buyer-friendly conditions for most insurance lines, which began in late 2024 and have continued throughout the first and second quarters of 2025